House Of Commons Committee Of Public Accounts Access To Clinical Trial Information And The Stockpiling Of Tamiflu Hc 295

Download House Of Commons Committee Of Public Accounts Access To Clinical Trial Information And The Stockpiling Of Tamiflu Hc 295 full books in PDF, epub, and Kindle. Read online free House Of Commons Committee Of Public Accounts Access To Clinical Trial Information And The Stockpiling Of Tamiflu Hc 295 ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

House of Commons - Committee of Public Accounts: Access to Clinical Trial Information and the Stockpiling of Tamiflu - HC 295

House of Commons - Committee of Public Accounts: Access to Clinical Trial Information and the Stockpiling of Tamiflu - HC 295
Author :
Publisher : The Stationery Office
Total Pages : 52
Release :
ISBN-10 : 0215065972
ISBN-13 : 9780215065971
Rating : 4/5 (971 Downloads)

Book Synopsis House of Commons - Committee of Public Accounts: Access to Clinical Trial Information and the Stockpiling of Tamiflu - HC 295 by : Great Britain: Parliament: House of Commons: Committee of Public Accounts

Download or read book House of Commons - Committee of Public Accounts: Access to Clinical Trial Information and the Stockpiling of Tamiflu - HC 295 written by Great Britain: Parliament: House of Commons: Committee of Public Accounts and published by The Stationery Office. This book was released on 2014-01-03 with total page 52 pages. Available in PDF, EPUB and Kindle. Book excerpt: The report Access To Clinical Trial Information And The Stockpiling Of Tamiflu (HC 295) examines two separate but connected issues; the routine withholding of clinical trial information from doctors and researchers, and the effectiveness of stockpiling of Tamiflu during an influenza pandemic. The full results of clinical trials are being routinely and legally withheld from doctors and researchers by the manufacturers of medicines. The ability of doctors, researchers and patients to make informed decisions about treatments is being undermined. Regulators and the industry have recently made proposals to open up access, but these do not cover the issue of access to the results of trials in the past which bear on the efficacy and safety of medicines in use today. Research suggests that the probability of completed trials being published is roughly 50%. Trials which give a favorable verdict are about twice as likely to be published as trials giving unfavorable


House of Commons - Committee of Public Accounts: Access to Clinical Trial Information and the Stockpiling of Tamiflu - HC 295 Related Books